Senolytic capacity of Obinutuzumab in t(14;18)-positive GCB DLBCL cell lines

Stegemann, M. (Speaker)

Department of Internal Medicine 3 - Hematology and Internal Oncology

Activity: Talk or presentation › Poster presentation › science-to-science

Period	24 May 2024
Event title	unbekannt/unknown
Event type	Conference
Location	GermanyShow on map

Fields of science

302024 Haematology
302055 Oncology